<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1109400</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2022.1109400</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Research trends and hotspots of neurodegenerative diseases employing network pharmacology: A bibliometric analysis</article-title>
<alt-title alt-title-type="left-running-head">Zhu et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2022.1109400">10.3389/fphar.2022.1109400</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liang</surname>
<given-names>Qingchun</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Siyi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Chen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Xiafei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Duozhi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lin</surname>
<given-names>Guanwen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Zhihua</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2113109/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Anesthesiology</institution>, <institution>Hainan General Hospital</institution>, <institution>Hainan Affiliated Hospital of Hainan Medical University</institution>, <addr-line>Haikou</addr-line>, <addr-line>Hainan</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Anesthesiology</institution>, <institution>The Third Affiliated Hospital</institution>, <institution>Southern Medical University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/655131/overview">Rui Liu</ext-link>, Chinese Academy of Medical Sciences, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/697752/overview">Ling-Feng Zeng</ext-link>, Guangdong Provincial Hospital of Chinese Medicine, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/678637/overview">Fang Ye</ext-link>, Sun Yat-sen University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Guanwen Lin, <email>lingw0000@163.com</email>; Zhihua Wang, <email>wangzhihua@hainmc.edu.cn</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work and share first authorship</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>01</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>1109400</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>12</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Zhu, Liang, He, Wang, Lin, Wu, Lin and Wang.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Zhu, Liang, He, Wang, Lin, Wu, Lin and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Background:</bold> Employing network pharmacology in neurodegenerative diseases (NDs) has been extensively studied recently. However, no comprehensive study has conducted on this subject employing bibliometrics so far. The purpose of this study was to find out the developmental trends and hotspots, and to predict potential research directions in this filed.</p>
<p>
<bold>Methods:</bold> Relevant research were collected from the Web of Science Core Collection Bibliometrics and visual analysis were executed using CiteSpace, VOSviewer, Histcite and R-bibliometrix.</p>
<p>
<bold>Results:</bold> A total of 420 English articles on network pharmacology in NDs published in 2008&#x2013;2022 were obtained from the WOSCC database. From 2008 to 2022, annual publications showed a steady growing trend, especially in 2014&#x2013;2022. China, Beijing Univ Chinese Med, Frontiers in Pharmacology, and Geerts H are the most prolific country, institution, journal, and author, respectively. China, Nucleic Acids Research, and Hopkins AL are the most highly cited country, journal, and author, respectively. Moreover, network pharmacology and Alzheimer&#x2019;s disease are the focal areas of current researches according to analysis of co-cited references and keywords. Finally, in the detection of burst keywords, systems pharmacology and database are new approaches to disease and drug research, while traditional Chinese medicine (TCM) and Alzheimer&#x2019;s disease are hot research directions. The above keywords are speculated to be the research frontiers.</p>
<p>
<bold>Conclusion:</bold> Network pharmacology and Alzheimers&#x2019; disease are the main topics of researches on network pharmacology in NDs. Network pharmacology and the TCM treatment of Alzheimer&#x2019;s disease have been the recent research hotspots. To sum up, the potential for exploring TCM treatment of AD with network pharmacology is huge.</p>
</abstract>
<kwd-group>
<kwd>network pharmacology</kwd>
<kwd>neurodegenerative diseases</kwd>
<kwd>Alzheimer&#x2019;s disease</kwd>
<kwd>traditional Chinese medicine</kwd>
<kwd>Citespace</kwd>
<kwd>VOSviewer</kwd>
<kwd>bibliometrics</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Neurodegenerative diseases (NDs) refers to a range of brain and spinal cord diseases caused by progressive neuronal damage (<xref ref-type="bibr" rid="B38">MT, 2016</xref>). It is characterized by disease-specific protein misfolding, accumulation, and aggregation etc (<xref ref-type="bibr" rid="B13">Dugger and Dickson, 2017</xref>). It includes two main types: one primarily affects memory and cognitive function, such as Alzheimer&#x2019;s disease (AD), the other chiefly influences motor function, such as Parkinson disease (PD) (<xref ref-type="bibr" rid="B46">Solanki et al., 2016</xref>). In recent years, the incidence of neurodegenerative disease has been increasing (<xref ref-type="bibr" rid="B30">Hou et al., 2019</xref>). AD is the most common neurodegenerative disease at present, followed by PD (<xref ref-type="bibr" rid="B21">GBD 2016 Dementia Collaborators, 2019</xref>). However, these diseases can not be completely cured (<xref ref-type="bibr" rid="B49">The Lancet, 2016</xref>), in fact can only be improved by alleviating associated symptoms (<xref ref-type="bibr" rid="B4">Breijyeh and Karaman, 2020</xref>). Therefore, further researches on the treatment of NDs may be the general trend. A number of Chinese herbal medicines with antioxidant and anti-inflammatory properties have been proved to be beneficial in the treatment of NDs (<xref ref-type="bibr" rid="B35">Li et al., 2014</xref>).</p>
<p>Traditional Chinese medicine (TCM) is marked by its complex components, multiple targets and complicated pathways of activation (<xref ref-type="bibr" rid="B51">Wang et al., 2018</xref>). Traditionally, it has been difficult to explain how TCM formulae work in terms of pharmacodynamics and rules of action. Network pharmacology integrates high-throughput data integration, target conjecture, information mining and database retrieval etc (<xref ref-type="bibr" rid="B26">He et al., 2022</xref>). The emergence of network pharmacology depends on the expeditious development of systems biology and network technology. Based on the interaction network of drugs, diseases and targets, the intervention and influence of drugs on the body&#x2019;s disease network can be completely understood, and the discovery of new drugs and new targets can be guided (<xref ref-type="bibr" rid="B40">Nogales et al., 2022</xref>). As a new paradigm to guide drug development and application, network pharmacology now is widely used in the exploration of many diseases and drugs (<xref ref-type="bibr" rid="B33">Lai et al., 2020</xref>). The holistic and systematic view of network pharmacology coincides with TCM, and plays a critical role in exploring the targets, understanding the biological basis of diseases and syndromes, and illuminating the regulatory mechanism of traditional Chinese herbal medicines (<xref ref-type="bibr" rid="B52">Wang et al., 2021</xref>). For example, sildenafil was identified as a potential Alzheimer&#x2019;s disease drug candidate through network medicine strategy (<xref ref-type="bibr" rid="B18">Fang et al., 2021</xref>) recently. Nevertheless, there are no studies systematically analyzed and visualized the researches on the network pharmacology in NDs.</p>
<p>In contrast to traditional reviews, bibliometrics analyzes published articles information and related data, applying statistical methods to describe or visualize the relationship between articles (<xref ref-type="bibr" rid="B39">Ninkov et al., 2022</xref>). Bibliometrics has been widely used to track the evolution and development of knowledge fields as well as to identify potential research hotspots (<xref ref-type="bibr" rid="B6">Chen, 2004</xref>). Through the visual display of bibliometrics, researcher can identify the development of a certain field more intuitively, comprehensively and systematically (<xref ref-type="bibr" rid="B9">Chen et al., 2020</xref>). At present, no bibliometric research has conducted on the network pharmacology in NDs. Therefore, our study aims to show evolutionary trends and emerging hotspots of researches on network pharmacology in NDs, provide guidance for further research direction and scientific decision-making based on the WoSCC database by using visual tools.</p>
</sec>
<sec sec-type="methods" id="s2">
<title>Methods</title>
<sec id="s2-1">
<title>Data sources and search strategies</title>
<p>Relevant data was searched and obtained from the WoSCC in 2008&#x2013;2022. Literature retrieval was conducted within a day (4 September 2022) to avoid fluctuations in rapid updates of publications. The search formula was constructed to TS&#x3d; (&#x201c;Neurodegenerative&#x201d; OR &#x201c;Neurologic Degenerative&#x201d; OR &#x201c;Nervous System Degenerative&#x201d; OR &#x201c;Neurodegenerative Disorder&#x201d; OR &#x201c;Neurologic Degenerative Condition&#x201d; OR &#x201c;Neurologic Degenerative&#x201d; OR &#x201c;Degenerative Neurologic Disorder&#x201d; OR Degenerative OR &#x201c;Alzheimer Disease&#x201d; OR &#x201c;Cognitive dysfunction&#x201d; OR &#x201c;Brain&#x201d; OR &#x201c;Alzheimer&#x2019;s disease&#x201d; OR Alzheimer OR AD OR &#x201c;Parkinson&#x2019;s disease&#x201d; OR PD OR &#x201c;Huntington disease&#x201d; OR &#x201c;Huntington&#x2019;s disease&#x201d; OR HD OR &#x201c;Amyotrophic lateral sclerosis&#x201d; OR ALS OR &#x201c;Spinal cord cerebellar ataxia&#x201d; OR SCA OR &#x201c;multiple sclerosis&#x2a;&#x201c;) AND TS&#x3d; (&#x201c;network pharmacology&#x201d; OR &#x201c;systems pharmacology&#x201d; OR &#x201c;network medicine&#x201d;). A total of 752 articles were retrieved, the main types of literatures chosen for our study were articles and reviews, and the language was confined to English. Two researchers (ZJ and HSY) independently performed the original literatures search and identify any possible errors and discrepancies. Besides, they read the titles, abstracts, and even the full texts of paper to filter out papers that are closely related to our subject. Only 420 publications were enrolled. The detailed retrieval process was shown in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Flow chart of literature retrieval.</p>
</caption>
<graphic xlink:href="fphar-13-1109400-g001.tif"/>
</fig>
</sec>
<sec id="s2-2">
<title>Statistical analysis</title>
<p>In this study, visual analysis was constructed using Microsoft Office Excel 2019, HistCite (version 2009.08.24), VOSviewer (version1.6.18), CiteSpace (version6.1), and Bibliometrix 4.1.0 Packages based on the R language.</p>
<p>Microsoft Excel was employed to make the tables and display the information of countries, authors, institutions and references.</p>
<p>HistCite, a document indexing and analysis software designed to process information from literature searches, helps scholars master the historical development of a field and identifies highly cited research and scholars (<xref ref-type="bibr" rid="B23">Garfield et al., 2006</xref>). In present study, it was used in calculating the publications, reference citation, total local citation score (TLCS) and total global citation score (TGCS). TLCS refers to total citations in the collection, which can reveal the popularity of the article in this field and is usually less than TGCS. And TGCS refers to total citations in Web of Science to papers in the collection. Although TGCS does not directly reveal the focus of the field, it can still help to find the most influential work in all disciplines.</p>
<p>Vosviewer, a software for building a visual bibliometric network based on network data (<xref ref-type="bibr" rid="B50">van Eck and Waltman, 2010</xref>), is hired to construct visual network atlas for systematically understanding the structure and dynamic development of scientific researches. In this study, VOSviewer 1.6.18 was used to visualize the cooperative networks of productive countries, journals and authors based on bibliographic data.</p>
<p>CiteSpace is a citation analysis software based on scientometrics, data, and information visualization to visualize the distribution, patterns, and relationships of scientific knowledge (<xref ref-type="bibr" rid="B6">Chen, 2004</xref>). It can build visual networks, compute intermediary centrality, and perform burst detection to reveal changes in emerging trends, identify research frontiers (<xref ref-type="bibr" rid="B10">Chen et al., 2012</xref>), and tag key keywords (<xref ref-type="bibr" rid="B5">Chen, 2006</xref>). The visualization map is composed of nodes and lines (<xref ref-type="bibr" rid="B7">Chen and Song, 2019</xref>). Nodes are sized based on the number of items, and connections between nodes indicate co-occurrences, collaborations, or citations. The betweenness centrality measure quantifies the importance and connectivity of a node&#x2019;s position within the network. The higher the betweenness centrality it is, the more connections it passes through (<xref ref-type="bibr" rid="B19">Freeman, 1978</xref>). Circles with a betweenness centrality over 0.1 were highlighted in purple. In clustering, the modularity Q and mean silhouette value are the most important parameters. Clusters were considered dominant and persuasive when Q &#x3e; 0.3 and mean silhouette value &#x3e;0.5 (<xref ref-type="bibr" rid="B54">Xu et al., 2022</xref>). In present study, CiteSpace was employed to analyze co-cited authors and documents. CiteSpace can also identify burst citations and keywords. Basic parameters of CiteSpace were set according to our previous study (<xref ref-type="bibr" rid="B12">Dong et al., 2021</xref>).</p>
<p>The bibliometrix package in R 4.1.0 was used to automate the transformation and analysis of bibliographic information for selected publications, including institutional and periodical outputs, as well as author impact indicators. Indicators including number of publications and number of citations were used to evaluate the impact factors of the authors. The h-index commonly used to assess the level of academic output of a researcher (<xref ref-type="bibr" rid="B3">Bertoli-Barsotti and Lando, 2017</xref>), higher h-indix indicates higher scholarly impact (<xref ref-type="bibr" rid="B28">Hirsch, 2005</xref>). As a derivative index of h-index, g-index can further measure the academic impact and achievements of scholars (<xref ref-type="bibr" rid="B1">Ali, 2021</xref>).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Analysis of publication outputs and citation</title>
<p>A total of 420 English articles related to the network pharmacology in NDs were included. <xref ref-type="fig" rid="F2">Figure 2A</xref> revealed an overall growing trend for annual and cumulative quantity of publications released from 2008 to 2022. <xref ref-type="fig" rid="F2">Figure 2B</xref> showed that annual number of TGCS peaked in 2014 (<italic>n</italic> &#x3d; 1934), and TLCS peaked in 2018 (<italic>n</italic> &#x3d; 31). 2014&#x2013;2022 was a period of stable development in this field with 394 publications. However, TGCS and TLCS fluctuated during this period. The above results showed that although the number of citations fluctuated, the overall volume continued to grow sharply.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Overall distribution of publication outputs and citations on network pharmacology in NDs. <bold>(A)</bold> Number and trends of annual and cumulative publications. <bold>(B)</bold> Annual number of TLCS and TGCS.</p>
</caption>
<graphic xlink:href="fphar-13-1109400-g002.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Distribution of countries/regions</title>
<p>From 2008 to 2022, a total of 53 countries participated in the research on network pharmacology in NDs. The United States had close connections with European countries (<xref ref-type="fig" rid="F3">Figure 3A</xref>). China was the most prolific country (256 publications), followed by the United States (109 publications) and the UK (26 publications) (<xref ref-type="fig" rid="F3">Figure 3B</xref>). There was a rising trend in the number of publications in the main distribution countries (<xref ref-type="fig" rid="F3">Figure 3C</xref>). In <xref ref-type="fig" rid="F3">Figure 3D</xref>, nodes are sized according to the number of publications, the lines indicate the cooperation, and thickness of line represents the strength of connections. China had the highest quantity of publications, while the United States had more links between other countries. Additionally, The US, Italy and China had the highest centrality over 0.1 (<xref ref-type="table" rid="T1">Table 1</xref>), indicating that these countries were the major research centers in the area of the network pharmacology in NDs. According to <xref ref-type="fig" rid="F3">Figure 3E</xref>, although China had a great number of articles, it had a low proportion of co-operation with authors from other countries. The most cited countries were China (3,525), followed by United States (1,760) and Italy (801) (<xref ref-type="fig" rid="F3">Figure 3F</xref>). The results mentioned above pointed out that China and the United States had significant contributions and influence in this field.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Analysis of countries/regions. <bold>(A)</bold> World map of the intensity of cooperation between countries. <bold>(B)</bold> Publications of the top 10 countries. <bold>(C)</bold> Distribution of the countries/regions&#x2019; publications over time. <bold>(D)</bold> Cooperation network of countries. <bold>(E)</bold> Distribution of corresponding author&#x2019;s country. MCP refers to the number of papers co-authored with different countries, and SCP refers to the number of papers co-authored with same countries. <bold>(F)</bold> Radar map of TGCS of the top 10 productive countries.</p>
</caption>
<graphic xlink:href="fphar-13-1109400-g003.tif"/>
</fig>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Top 10 countries by publications, citations and centrality.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Rank</th>
<th align="center">Country</th>
<th align="center">Publications</th>
<th align="center">TGCS<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</th>
<th align="center">Average citations</th>
<th align="center">Rank</th>
<th align="center">Country</th>
<th align="center">Centrality</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="center">China</td>
<td align="center">256</td>
<td align="center">3,525</td>
<td align="center">13.77</td>
<td align="center">1</td>
<td align="center">United States of America</td>
<td align="center">0.53</td>
</tr>
<tr>
<td align="left">2</td>
<td align="center">United States of America</td>
<td align="center">109</td>
<td align="center">1,760</td>
<td align="center">16.15</td>
<td align="center">2</td>
<td align="center">Italy</td>
<td align="center">0.38</td>
</tr>
<tr>
<td align="left">3</td>
<td align="center">United Kingdom</td>
<td align="center">26</td>
<td align="center">406</td>
<td align="center">15.62</td>
<td align="center">3</td>
<td align="center">China</td>
<td align="center">0.2</td>
</tr>
<tr>
<td align="left">4</td>
<td align="center">India</td>
<td align="center">19</td>
<td align="center">98</td>
<td align="center">5.16</td>
<td align="center">4</td>
<td align="center">United Kingdom</td>
<td align="center">0.17</td>
</tr>
<tr>
<td align="left">5</td>
<td align="center">Italy</td>
<td align="center">19</td>
<td align="center">801</td>
<td align="center">42.16</td>
<td align="center">5</td>
<td align="center">Spain</td>
<td align="center">0.17</td>
</tr>
<tr>
<td align="left">6</td>
<td align="center">Germany</td>
<td align="center">17</td>
<td align="center">237</td>
<td align="center">13.94</td>
<td align="center">6</td>
<td align="center">Ireland</td>
<td align="center">0.14</td>
</tr>
<tr>
<td align="left">7</td>
<td align="center">Netherlands</td>
<td align="center">16</td>
<td align="center">215</td>
<td align="center">13.44</td>
<td align="center">7</td>
<td align="center">Turkey</td>
<td align="center">0.14</td>
</tr>
<tr>
<td align="left">8</td>
<td align="center">Russia</td>
<td align="center">8</td>
<td align="center">75</td>
<td align="center">9.38</td>
<td align="center">8</td>
<td align="center">Russia</td>
<td align="center">0.11</td>
</tr>
<tr>
<td align="left">9</td>
<td align="center">Spain</td>
<td align="center">8</td>
<td align="center">227</td>
<td align="center">28.38</td>
<td align="center">9</td>
<td align="center">Germany</td>
<td align="center">0.09</td>
</tr>
<tr>
<td align="left">10</td>
<td align="center">Belgium</td>
<td align="center">7</td>
<td align="center">156</td>
<td align="center">22.29</td>
<td align="center">10</td>
<td align="center">Hungary</td>
<td align="center">0.08</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>
<sup>a</sup>
</label>
<p>TGCS, total global citation score.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-3">
<title>Analysis of institutions</title>
<p>Information visualization helps to identify influential institutions and clarify their cooperation. Chinese institutions are the main driving force in this area and top three institutions ranked by centrality were China Acad Chinese Med Sci (0.06), Guangzhou Univ Chinese Med (0.04) and Beijing Univ Chinese Med (0.03) (<xref ref-type="fig" rid="F4">Figure 4A</xref>; <xref ref-type="table" rid="T2">Table 2</xref>). However, their centrality were less than 0.1, indicating that there are no key research center and sufficient inter-agency cooperation among the top 10 institutions. Beijing Univ Chinese Med (24 publications), China Acad Chinese Med Sci (17 publications), Guangzhou Univ Chinese Med (16 publications) were the top three highly productive institutions in this field (<xref ref-type="fig" rid="F4">Figure 4B</xref>; <xref ref-type="table" rid="T2">Table 2</xref>). Although Chinese Acad Sci was not the institution with the largest number of publications, it had the highest TGCS, representing its great influences in all disciplines. In <xref ref-type="fig" rid="F4">Figures 4C, D</xref>, the institutions owning five or more publications were used to create collaboration network. Inter-agency collaboration is considered crucial motivation to conduct large-scale research. We observed that the cooperative relationship between institutions was relatively simple, and correlation was not close. In short, China is the main driving force in this filed, but interagency cooperation still needs to be strengthened.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Analysis of institutions. <bold>(A)</bold> Visualization of institutions involved in network pharmacology in NDs. <bold>(B)</bold> Top 10 institutions of publications. <bold>(C)</bold> Cooperation network of institutions. <bold>(D)</bold> Density map of institutions cooperation.</p>
</caption>
<graphic xlink:href="fphar-13-1109400-g004.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Top 10 institutions distributed by publications and centrality.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Rank</th>
<th align="center">Institution</th>
<th align="center">Publications</th>
<th align="center">TGCS<xref ref-type="table-fn" rid="Tfn2">
<sup>a</sup>
</xref>
</th>
<th align="center">Original country</th>
<th align="center">Institution</th>
<th align="center">Centrality</th>
<th align="center">Original country</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="center">Beijing Univ Chinese Med</td>
<td align="center">24</td>
<td align="center">84</td>
<td align="center">China</td>
<td align="center">China Acad Chinese Med Sci</td>
<td align="center">0.06</td>
<td align="center">China</td>
</tr>
<tr>
<td align="left">2</td>
<td align="center">China Acad Chinese Med Sci</td>
<td align="center">17</td>
<td align="center">197</td>
<td align="center">China</td>
<td align="center">Guangzhou Univ Chinese Med</td>
<td align="center">0.04</td>
<td align="center">China</td>
</tr>
<tr>
<td align="left">3</td>
<td align="center">Guangzhou Univ Chinese Med</td>
<td align="center">16</td>
<td align="center">248</td>
<td align="center">China</td>
<td align="center">Beijing Univ Chinese Med</td>
<td align="center">0.03</td>
<td align="center">China</td>
</tr>
<tr>
<td align="left">4</td>
<td align="center">Chinese Acad Sci</td>
<td align="center">13</td>
<td align="center">1,851</td>
<td align="center">China</td>
<td align="center">Tianjin Univ Tradit Chinese Med</td>
<td align="center">0.03</td>
<td align="center">China</td>
</tr>
<tr>
<td align="left">5</td>
<td align="center">Shanghai Univ Tradit Chinese Med</td>
<td align="center">12</td>
<td align="center">69</td>
<td align="center">China</td>
<td align="center">Chinese Acad Sci</td>
<td align="center">0.02</td>
<td align="center">China</td>
</tr>
<tr>
<td align="left">6</td>
<td align="center">Harvard Med Sch</td>
<td align="center">11</td>
<td align="center">242</td>
<td align="center">United States of America</td>
<td align="center">Capital Med Univ</td>
<td align="center">0.02</td>
<td align="center">China</td>
</tr>
<tr>
<td align="left">7</td>
<td align="center">Tianjin Univ Tradit Chinese Med</td>
<td align="center">10</td>
<td align="center">87</td>
<td align="center">China</td>
<td align="center">Shaanxi Univ Chinese Med</td>
<td align="center">0.01</td>
<td align="center">China</td>
</tr>
<tr>
<td align="left">8</td>
<td align="center">Univ Penn</td>
<td align="center">10</td>
<td align="center">255</td>
<td align="center">United States of America</td>
<td align="center">Case Western Reserve Univ</td>
<td align="center">0.01</td>
<td align="center">United States of America</td>
</tr>
<tr>
<td align="left">9</td>
<td align="center">Univ Pittsburgh</td>
<td align="center">10</td>
<td align="center">69</td>
<td align="center">United States of America</td>
<td align="center">Guangdong Pharmaceut Univ</td>
<td align="center">0.01</td>
<td align="center">China</td>
</tr>
<tr>
<td align="left">10</td>
<td align="center">Leiden Univ</td>
<td align="center">9</td>
<td align="center">82</td>
<td align="center">Netherlands</td>
<td align="center">Fudan Univ</td>
<td align="center">0.01</td>
<td align="center">China</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn2">
<label>
<sup>a</sup>
</label>
<p>TGCS, total global citation score.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-4">
<title>Analysis of authors and Co-Cited authors</title>
<p>A total of 2,511 authors contributed to researches on network pharmacology in NDs. Geerts H, from the United States, had the largest number of publications (25), followed by Fang JS (12) and Spiros A (12) (<xref ref-type="table" rid="T3">Table 3</xref>). Moreover, most of the influential authors were from China and the United States. As shown in <xref ref-type="fig" rid="F5">Figure 5A</xref>, Geerts H cooperated closely with Roberts P, Carr R and Spiros A. In addition, Fang JS frequently collaborated with Wang Q. In <xref ref-type="fig" rid="F5">Figures 5B&#x2013;D</xref>, Geerts H had the largest number of publications, highest H-index and G-index, indicating his outstanding contribution to this field. As early entrants into the field, Geerts H and Spiros A continued to publish related papers from 2012 to 2021, and Geerts H almost had important outputs each year (<xref ref-type="fig" rid="F5">Figure 5E</xref>). As noted in <xref ref-type="fig" rid="F5">Figure 5F</xref>, Hopkins AL had the highest co-citations, followed by Ru JL and Shannon P, with centrality more than 0.1 marked with purple rings, suggesting that they had strong academic influences in this field.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Top 10 authors distributed by publications.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Rank</th>
<th align="center">Author</th>
<th align="center">Publications</th>
<th align="center">Publications as key author<xref ref-type="table-fn" rid="Tfn3">
<sup>a</sup>
</xref>
</th>
<th align="center">Country</th>
<th align="center">Institution</th>
<th align="center">TGCS<xref ref-type="table-fn" rid="Tfn4">
<sup>b</sup>
</xref>
</th>
<th align="center">TLCS<xref ref-type="table-fn" rid="Tfn5">
<sup>c</sup>
</xref>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">1</td>
<td align="center">Geerts H</td>
<td align="center">25</td>
<td align="center">19</td>
<td align="center">United States</td>
<td align="center">Silico Biosciences Perelman School of Medicine</td>
<td align="center">374</td>
<td align="center">45</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">Fang JS</td>
<td align="center">12</td>
<td align="center">10</td>
<td align="center">China</td>
<td align="center">Guangzhou University of Chinese Medicine</td>
<td align="center">210</td>
<td align="center">28</td>
</tr>
<tr>
<td align="center">3</td>
<td align="center">Spiros A</td>
<td align="center">12</td>
<td align="center">1</td>
<td align="center">United States</td>
<td align="center">Silico Biosciences Perelman School of Medicine</td>
<td align="center">200</td>
<td align="center">22</td>
</tr>
<tr>
<td align="center">4</td>
<td align="center">Wang q</td>
<td align="center">9</td>
<td align="center">8</td>
<td align="center">China</td>
<td align="center">Guangzhou University of Chinese Medicine</td>
<td align="center">236</td>
<td align="center">20</td>
</tr>
<tr>
<td align="center">5</td>
<td align="center">Roberts P</td>
<td align="center">9</td>
<td align="center">2</td>
<td align="center">United States</td>
<td align="center">Silico Biosciences Perelman School of Medicine</td>
<td align="center">155</td>
<td align="center">18</td>
</tr>
<tr>
<td align="center">6</td>
<td align="center">Wang YH</td>
<td align="center">6</td>
<td align="center">5</td>
<td align="center">China</td>
<td align="center">Northwest A&#x26;F University</td>
<td align="center">1,828</td>
<td align="center">6</td>
</tr>
<tr>
<td align="center">7</td>
<td align="center">Cheng FX</td>
<td align="center">5</td>
<td align="center">5</td>
<td align="center">United States</td>
<td align="center">Cleveland Clinic</td>
<td align="center">81</td>
<td align="center">4</td>
</tr>
<tr>
<td align="center">8</td>
<td align="center">Fang SH</td>
<td align="center">5</td>
<td align="center">2</td>
<td align="center">China</td>
<td align="center">Guangzhou University of Chinese Medicine</td>
<td align="center">112</td>
<td align="center">14</td>
</tr>
<tr>
<td align="center">9</td>
<td align="center">Gao L</td>
<td align="center">5</td>
<td align="center">0</td>
<td align="center">China</td>
<td align="center">Shanxi University of Chinese Medicine</td>
<td align="center">125</td>
<td align="center">14</td>
</tr>
<tr>
<td align="center">10</td>
<td align="center">Wu QH</td>
<td align="center">4</td>
<td align="center">1</td>
<td align="center">China</td>
<td align="center">Hainan Provincial Hospital of Traditional Chinese Medicine</td>
<td align="center">45</td>
<td align="center">0</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn3">
<label>
<sup>a</sup>
</label>
<p>Publications as key author, the number of publications as first author or corresponding author.</p>
</fn>
<fn id="Tfn4">
<label>
<sup>b</sup>
</label>
<p>TGCS, total global citation score.</p>
</fn>
<fn id="Tfn5">
<label>
<sup>c</sup>
</label>
<p>TLCS, total local citation score.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Analysis of authors and co-cited authors. <bold>(A)</bold> Cooperation network of authors, 112 authors had published at least three documents. <bold>(B)</bold> Top 10 authors in terms of number of publications. <bold>(C)</bold> Top 10 authors in terms of H-index <bold>(D)</bold> Top 10 authors in terms of G-index. <bold>(E)</bold> The top 10 authors&#x2019; production over time. <bold>(F)</bold> CiteSpace visualization of co-cited authors.</p>
</caption>
<graphic xlink:href="fphar-13-1109400-g005.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Analysis of journals</title>
<p>All articles are distributed in 193 journals, and four of these journals have more than 10 papers. We derived impact factors (IF) and journal quartiles from the 2021 Journal Citation Reports. The top three high-yield journals were Frontiers in Pharmacology (IF5.988), Evidence-based Complementary and Alternative Medicine (IF2.650), and Journal of Ethnopharmacology (IF5.195). The top 10 most productive journals in <xref ref-type="table" rid="T4">Table 4</xref> were mainly ranked in Q1 or Q2, indicating that the above journals had high scholastic reputations in this field. The three most frequently cited journals were Nucleic Acids Research (IF19.160), PLoS One (IF3.752) and Journal of Ethnopharmacology (IF5.195) <bold>(</bold>
<xref ref-type="fig" rid="F6">Figure 6A</xref>
<bold>)</bold>. The distribution of scientific journal issues is shown in a double map overlay (<xref ref-type="fig" rid="F6">Figure 6B</xref>). The double map overlay of journals displayed one core citation way, the citation journals are mainly distributed in the area of molecular, biology and immunology, and the cited articles published in journals were predominantly contained in the area of molecular, biology and genetics.</p>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Top 10 journals distributed by publications.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Rank</th>
<th align="center">Journal</th>
<th align="center">Publications</th>
<th align="center">% Of 420</th>
<th align="center">IF(JCR 2021)</th>
<th align="center">TGCS</th>
<th align="center">JIF quartile</th>
<th align="center">H-index</th>
<th align="center">G-index</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="center">Frontiers in pharmacology</td>
<td align="center">39</td>
<td align="center">9.28</td>
<td align="center">5.988</td>
<td align="center">292</td>
<td align="center">Q1</td>
<td align="center">12</td>
<td align="center">16</td>
</tr>
<tr>
<td align="left">2</td>
<td align="center">Evidence-based complementary and alternative medicine</td>
<td align="center">33</td>
<td align="center">7.86</td>
<td align="center">2.650</td>
<td align="center">108</td>
<td align="center">Q3</td>
<td align="center">6</td>
<td align="center">9</td>
</tr>
<tr>
<td align="left">3</td>
<td align="center">Journal of ethnopharmacology</td>
<td align="center">19</td>
<td align="center">4.52</td>
<td align="center">5.195</td>
<td align="center">334</td>
<td align="center">Q1</td>
<td align="center">10</td>
<td align="center">15</td>
</tr>
<tr>
<td align="left">4</td>
<td align="center">International journal of molecular sciences</td>
<td align="center">10</td>
<td align="center">2.38</td>
<td align="center">6.208</td>
<td align="center">170</td>
<td align="center">Q1</td>
<td align="center">7</td>
<td align="center">7</td>
</tr>
<tr>
<td align="left">5</td>
<td align="center">CPT-pharmacometrics and systems pharmacology</td>
<td align="center">9</td>
<td align="center">2.38</td>
<td align="center">4.339</td>
<td align="center">82</td>
<td align="center">Q2</td>
<td align="center">5</td>
<td align="center">8</td>
</tr>
<tr>
<td align="left">6</td>
<td align="center">Frontiers in aging neuroscience</td>
<td align="center">8</td>
<td align="center">1.90</td>
<td align="center">5.702</td>
<td align="center">53</td>
<td align="center">Q1</td>
<td align="center">3</td>
<td align="center">3</td>
</tr>
<tr>
<td align="left">7</td>
<td align="center">Molecules</td>
<td align="center">8</td>
<td align="center">1.90</td>
<td align="center">4.927</td>
<td align="center">67</td>
<td align="center">Q2</td>
<td align="center">5</td>
<td align="center">6</td>
</tr>
<tr>
<td align="left">8</td>
<td align="center">Phytomedicine</td>
<td align="center">8</td>
<td align="center">1.90</td>
<td align="center">6.656</td>
<td align="center">41</td>
<td align="center">Q1</td>
<td align="center">4</td>
<td align="center">6</td>
</tr>
<tr>
<td align="left">9</td>
<td align="center">Alzheimers and dementia</td>
<td align="center">7</td>
<td align="center">1.67</td>
<td align="center">16.655</td>
<td align="center">179</td>
<td align="center">Q1</td>
<td align="center">5</td>
<td align="center">5</td>
</tr>
<tr>
<td align="left">10</td>
<td align="center">Biomedicine and pharmacotherapy</td>
<td align="center">7</td>
<td align="center">1.67</td>
<td align="center">7.419</td>
<td align="center">94</td>
<td align="center">Q1</td>
<td align="center">4</td>
<td align="center">7</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Analysis of journals and co-cited journals. <bold>(A)</bold>Top 10 co-cited journals. <bold>(B)</bold> Dual-map overlay of journals.</p>
</caption>
<graphic xlink:href="fphar-13-1109400-g006.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>Analysis of cited and co-cited references</title>
<p>
<xref ref-type="table" rid="T5">Table 5</xref> lists the highly cited articles, the top cited article was &#x201c;TCMSP: a database of systems pharmacology for drug discovery from herbal medicines&#x201d; by Ru JL in 2014 (94 citations), followed by Shannon P in 2003 (73 citations) and Hopkins AL in 2008 (68 citations). We built a visualization network of co-cited references (<xref ref-type="fig" rid="F7">Figure 7A</xref>). &#x201c;Wishart (2018),&#x201d; &#x201c;Szklarczyk D (2019),&#x201d; and &#x201c;Zhou YY (2019)&#x201d; were frequently co-cited. Cluster analysis divided most of the relevant terms related to network pharmacology in NDs into 12 main categories (<xref ref-type="table" rid="T6">Table 6</xref>). The top 5 clusters were &#x201c;network pharmacology,&#x201d; &#x201c;alzheimers disease,&#x201d; &#x201c;network medicine,&#x201d; &#x201c;systems biology,&#x201d; and &#x201c;quantitative systems pharmacology&#x201d;. The silhouette value (S) represents the mean contour value of a cluster. Generally, if S &#x3e; 0.5, cluster is considered proper, and if S &#x3e; 0.7, cluster is persuasive. In this research, the S values of the top 12 clusters were more than 0.7, indicating that clustering was considered credible. Among all clusters, &#x201c;network pharmacology&#x201d; (Cluster 0&#x23;) was the largest cluster containing 68 articles (<xref ref-type="table" rid="T6">Table 6</xref>), which mainly discussed the application and the development of network pharmacology. In addition, references with the strong citations burst were mainly concentrated in the three clusters of 0&#x23;, 1&#x23;, 2&#x23; (<xref ref-type="fig" rid="F7">Figure 7B</xref>), they also were the most recently formed clusters, suggesting that network pharmacology and alzheimers disease may be the latest hotspots.</p>
<table-wrap id="T5" position="float">
<label>TABLE 5</label>
<caption>
<p>Top 10 cited literatures.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Rank</th>
<th align="center">Citations<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>
</th>
<th align="center">Authors</th>
<th align="center">Title</th>
<th align="center">Source</th>
<th align="center">Year</th>
<th align="center">DOI</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="center">94</td>
<td align="center">Ru JL</td>
<td align="left">TCMSP: a database of systems pharmacology for drug discovery from herbal medicines</td>
<td align="center">J CHEMINFORMATICS</td>
<td align="center">2014</td>
<td align="center">10.1186/1758-2946-6-13</td>
</tr>
<tr>
<td align="left">2</td>
<td align="center">73</td>
<td align="center">Shannon P</td>
<td align="left">Cytoscape: a software environment for integrated models of biomolecular interaction networks</td>
<td align="center">GENOME RES</td>
<td align="center">2003</td>
<td align="center">10.1101/gr.1239303</td>
</tr>
<tr>
<td align="left">3</td>
<td align="center">68</td>
<td align="center">Hopkins AL</td>
<td align="left">Network pharmacology: the next paradigm in drug discovery</td>
<td align="center">NAT CHEM BIOL</td>
<td align="center">2008</td>
<td align="center">10.1038/nchembio.118</td>
</tr>
<tr>
<td align="left">4</td>
<td align="center">40</td>
<td align="center">Li S</td>
<td align="left">Traditional Chinese medicine network pharmacology: theory, methodology and application</td>
<td align="center">CHIN J NAT MEDICINES</td>
<td align="center">2013</td>
<td align="center">10.1016/S1875-5364 (13)60037-0</td>
</tr>
<tr>
<td align="left">5</td>
<td align="center">33</td>
<td align="center">Hopkins AL</td>
<td align="left">Network pharmacology</td>
<td align="center">NAT CHEM BIOL</td>
<td align="center">2007</td>
<td align="center">10.1038/nbt1007-1110</td>
</tr>
<tr>
<td align="left">6</td>
<td align="center">31</td>
<td align="center">Huang DW</td>
<td align="left">Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</td>
<td align="center">NAT PROTOC</td>
<td align="center">2009</td>
<td align="center">10.1038/nprot. 2008.211</td>
</tr>
<tr>
<td align="left">7</td>
<td align="center">29</td>
<td align="center">Barabasi AL</td>
<td align="left">Network medicine: a network-based approach to human disease</td>
<td align="center">NAT REV GENET</td>
<td align="center">2011</td>
<td align="center">10.1038/nrg2918</td>
</tr>
<tr>
<td align="left">8</td>
<td align="center">29</td>
<td align="center">Pinero J</td>
<td align="left">DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants</td>
<td align="center">NUCLEIC ACIDS RES</td>
<td align="center">2017</td>
<td align="center">10.1093/nar/gkw943</td>
</tr>
<tr>
<td align="left">9</td>
<td align="center">29</td>
<td align="center">Wishart DS</td>
<td align="left">DrugBank 5.0: a major update to the DrugBank database for 2018</td>
<td align="center">NUCLEIC ACIDS RES</td>
<td align="center">2018</td>
<td align="center">10.1093/nar/gkx1037</td>
</tr>
<tr>
<td align="left">10</td>
<td align="center">69</td>
<td align="center">Szklarczyk D</td>
<td align="left">STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</td>
<td align="center">NUCLEIC ACIDS RES</td>
<td align="center">2019</td>
<td align="center">10.1093/nar/gky1131</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>
<sup>a</sup>citations refers to the number of records in which this reference is cited in the obtained articles</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Analysis of most commonly cited references. <bold>(A)</bold> Visualization of co-cited references. <bold>(B)</bold> Cluster analysis of co-cited references. <bold>(C)</bold> Timeline graph of cluster analysis. <bold>(D)</bold> Top 11 references with the most strongest bursts.</p>
</caption>
<graphic xlink:href="fphar-13-1109400-g007.tif"/>
</fig>
<table-wrap id="T6" position="float">
<label>TABLE 6</label>
<caption>
<p>Top 12 largest clusters of co-cited references.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Cluster</th>
<th align="left">Label (LLR<xref ref-type="table-fn" rid="Tfn6">
<sup>a</sup>
</xref>)</th>
<th align="center">Size</th>
<th align="center">Silhouette</th>
<th align="center">Average year</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">&#x23;0</td>
<td align="left">network pharmacology</td>
<td align="center">68</td>
<td align="center">0.923</td>
<td align="center">2020</td>
</tr>
<tr>
<td align="left">&#x23;1</td>
<td align="left">alzheimers disease</td>
<td align="center">55</td>
<td align="center">0.833</td>
<td align="center">2021</td>
</tr>
<tr>
<td align="left">&#x23;2</td>
<td align="left">network medicine</td>
<td align="center">45</td>
<td align="center">0.909</td>
<td align="center">2020</td>
</tr>
<tr>
<td align="left">&#x23;3</td>
<td align="left">systems biology</td>
<td align="center">44</td>
<td align="center">1</td>
<td align="center">2018</td>
</tr>
<tr>
<td align="left">&#x23;4</td>
<td align="left">quantitative systems pharmacology</td>
<td align="center">44</td>
<td align="center">0.938</td>
<td align="center">2016</td>
</tr>
<tr>
<td align="left">&#x23;5</td>
<td align="left">polypharmacology</td>
<td align="center">35</td>
<td align="center">0.932</td>
<td align="center">2015</td>
</tr>
<tr>
<td align="left">&#x23;6</td>
<td align="left">xiao-xu-ming decoction</td>
<td align="center">25</td>
<td align="center">0.915</td>
<td align="center">2018</td>
</tr>
<tr>
<td align="left">&#x23;7</td>
<td align="left">adme</td>
<td align="center">24</td>
<td align="center">0.962</td>
<td align="center">2014</td>
</tr>
<tr>
<td align="left">&#x23;8</td>
<td align="left">alzheimers disease</td>
<td align="center">23</td>
<td align="center">0.993</td>
<td align="center">2011</td>
</tr>
<tr>
<td align="left">&#x23;9</td>
<td align="left">epimedii herba</td>
<td align="center">19</td>
<td align="center">0.921</td>
<td align="center">2020</td>
</tr>
<tr>
<td align="left">&#x23;13</td>
<td align="left">ache inhibitor</td>
<td align="center">10</td>
<td align="center">0.996</td>
<td align="center">2014</td>
</tr>
<tr>
<td align="left">&#x23;27</td>
<td align="left">molecular simulation</td>
<td align="center">4</td>
<td align="center">0.995</td>
<td align="center">2019</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn6">
<label>
<sup>a</sup>
</label>
<p>LLR, log likelihood ratio.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Furthermore, we build a timeline for clusters in <xref ref-type="fig" rid="F7">Figure 7C</xref>. Relatively, the application of network pharmacology and traditional Chinese medicine therapy of AD are newly concerned by researchers. <xref ref-type="fig" rid="F7">Figure 7D</xref> lists the 11 references with the strongest citation explosions from 2010 to 2022. The most cited article was from Ru JL in 2014, which also had the largest number of citations. Based on the burst time, Barabasi AL in 2011 and Roberts PD in 2012 were most prominent. Barabasi AL et al. through the way of network pharmacology, systematically explored diseases&#x2019; pathogenic factors, recognition pathways and molecular relationships between different phenotypes to identify drug targets and biomarkers for specific diseases (<xref ref-type="bibr" rid="B2">Barabasi et al., 2011</xref>). Roberts PD et al. explored the potential of quantitative systems pharmacology in assessing drug activity and mechanism by analyzing the differential efficacy of memantine in different stages of Alzheimer&#x2019;s disease (<xref ref-type="bibr" rid="B43">Roberts et al., 2012</xref>). The above results hinted that exploration and application of network pharmacology were widely concerned for a long time.</p>
</sec>
<sec id="s3-7">
<title>Analysis of keywords</title>
<p>According to visual analysis of keywords by CiteSpace (<xref ref-type="fig" rid="F8">Figure 8A</xref>), network pharmacology and Alzheimer&#x2019;s disease were the two most prominent words. As shown in <xref ref-type="table" rid="T7">Table 7</xref>, the most common keywords were: network pharmacology, Alzheimer&#x2019;s disease, brain, systems pharmacology and traditional Chinese medicine. Among them, double blind (0.24), inhibition (0.23), and amyloid precursor protein (0.2) showed highest intermediary centrality. The intermediary centrality represents the connectivity of a node, and the higher it is, the more terms can be connected through the node, indicating the importance of a node in the network.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Analysis of keywords. <bold>(A)</bold> CiteSpace visualization of keywords. <bold>(B)</bold> Top 15 keywords with the most strongest bursts.</p>
</caption>
<graphic xlink:href="fphar-13-1109400-g008.tif"/>
</fig>
<table-wrap id="T7" position="float">
<label>TABLE 7</label>
<caption>
<p>Top 10 keywords by frequency and centrality.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Rank</th>
<th align="center">Frequency</th>
<th align="center">Keyword</th>
<th align="center">Centrality</th>
<th align="center">Keyword</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="center">163</td>
<td align="left">network pharmacology</td>
<td align="center">0.24</td>
<td align="left">double blind</td>
</tr>
<tr>
<td align="left">2</td>
<td align="center">112</td>
<td align="left">alzheimers disease</td>
<td align="center">0.23</td>
<td align="left">inhibition</td>
</tr>
<tr>
<td align="left">3</td>
<td align="center">45</td>
<td align="left">brain</td>
<td align="center">0.20</td>
<td align="left">amyloid precursor protein</td>
</tr>
<tr>
<td align="left">4</td>
<td align="center">42</td>
<td align="left">systems pharmacology</td>
<td align="center">0.19</td>
<td align="left">mouse model</td>
</tr>
<tr>
<td align="left">5</td>
<td align="center">40</td>
<td align="left">traditional chinese medicine</td>
<td align="center">0.18</td>
<td align="left">disease</td>
</tr>
<tr>
<td align="left">6</td>
<td align="center">39</td>
<td align="left">activation</td>
<td align="center">0.18</td>
<td align="left">amyloid beta</td>
</tr>
<tr>
<td align="left">7</td>
<td align="center">38</td>
<td align="left">expression</td>
<td align="center">0.17</td>
<td align="left">apoptosis</td>
</tr>
<tr>
<td align="left">8</td>
<td align="center">33</td>
<td align="left">mechanism</td>
<td align="center">0.17</td>
<td align="left">schizophrenia</td>
</tr>
<tr>
<td align="left">9</td>
<td align="center">33</td>
<td align="left">model</td>
<td align="center">0.16</td>
<td align="left">deep brain stimulation</td>
</tr>
<tr>
<td align="left">10</td>
<td align="center">32</td>
<td align="left">inhibition</td>
<td align="center">0.15</td>
<td align="left">alzheimers disease</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Burst keywords detection can reveal the evolution of the topic, predict the development directions and excavate potential flash point. As shown in <xref ref-type="fig" rid="F7">Figure 7B</xref>, the keywords were mainly concentrated between 2012 and 2020. Besides, the burst keywords with strong strength were &#x201c;systems pharmacology,&#x201d; &#x201c;drug discovery,&#x201d; and &#x201c;discovery&#x201d;, indicating that the application of systems pharmacology and the search for drugs during this period may have been a major concern for researchers. Furthermore, &#x201c;amyloid precursor protein&#x201d; had been followed for the longest time, which was an important molecule in the pathogenesis of AD. In keyword burst detection, &#x201c;systematic pharmacology&#x201d; and &#x201c;drug discovery&#x201d; have highest intensity, &#x201c;amyloid precursor protein&#x201d; had longest sustained burst, and the latest bursts were concentrated in &#x201c;systematic pharmacology,&#x201d; &#x201c;database,&#x201d; &#x201c;traditional Chinese medicine,&#x201d; and &#x201c;alzheimers disease&#x201d; suggested that the current hotspots may be focused on the exploration of therapeutic methods for AD. Burst detection in this research contained major types, molecular mechanisms, and hot research methods of neurodegenerative diseases.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In this research, we utilized the method of bibliometrics to objectively analyze literatures allied to the network pharmacology in NDs. Our results suggested that the number of annual publications in this field had increased significantly in recent years, which showed that this field was receiving more and more attention. The number of publications and citations in a certain research field are considered to be significant index to evaluate academic reputation and scientific research ability of a country or institution (<xref ref-type="bibr" rid="B47">Soteriades and Falagas, 2005</xref>; <xref ref-type="bibr" rid="B55">Yadava et al., 2019</xref>). China ranked first in research in terms of publications, but average citation was not high, suggesting the quality of researches led by China was not satisfactory. As for institutes, most of the top 10 institutions were from China, but the cooperation between institutions was not strong. Beijing Univ Chinese Med has the most publications and Chinese Acad Sci ranked first in terms of TGCS. As the second prolific country, the United States had close cooperation with other countries, as well as the highest centrality in the cooperative network, representing high quality of its researches and far-reaching effects on other countries. Transnational cooperation has significant benefits in thinking innovation and model reform, becoming an important trend in future research (<xref ref-type="bibr" rid="B22">Gal et al., 2017</xref>). The above results indicated that Chinese institutions were dominant in this field, while United States had the best cooperation with other countries.</p>
<p>In addition, our results indicated that Geerts H was the most influential author. He focused on Alzheimer&#x2019;s drug research and made important contributions to the treatment of NDs. He devoted himself to using systems pharmacology to develop integrated models of compounds, mechanisms, and disease-level data (<xref ref-type="bibr" rid="B25">Geerts et al., 2020</xref>), explored intelligent and experience-based computer model (<xref ref-type="bibr" rid="B24">Geerts et al., 2016</xref>). The second most productive author was Fang JS from China, who was devoted to multiple studies of TCM and drug discovery in NDs. He proposed using network pharmacology to explore the potential mechanisms of the most widely used medicinal herbs of AD (<xref ref-type="bibr" rid="B14">Fang et al., 2017a</xref>). Besides, he established a predictive knowledge base (AlzhCPI) of chemical-protein interactions in AD (<xref ref-type="bibr" rid="B15">Fang et al., 2015</xref>), as well as a genome-wide positioning systems platform (AlzGPS) for AD drug discovery (<xref ref-type="bibr" rid="B59">Zhou et al., 2021</xref>), and constructed a worldwide drug-target network of natural products by integrating predicted drug-target interactions (DTI) (<xref ref-type="bibr" rid="B17">Fang et al., 2017b</xref>). Recently, he also proposed endophenotype-based network medicine approach to promote AD therapeutic development (<xref ref-type="bibr" rid="B16">Fang et al., 2020</xref>). Simultaneously, the most co-citations author was Hopkins AL. He proposed &#x201c;Network pharmacology&#x201d;, which was a new framework for thinking about how to innovate drug by understanding the biological and kinetic properties of drugs to improve clinical efficacy and recognize side effects and toxicities (<xref ref-type="bibr" rid="B29">Hopkins, 2008</xref>). The above authors enjoyed a high academic reputations and had made a significant contribution to the developments and progress in the field relative to network pharmacology in NDs.</p>
<p>In this research, most prolific journals were divided into Q1 or Q2, and Alzheimer &#x26; Dementia (IF16.655) had the highest IF. Frontiers in Pharmacology (IF5.998) were the journal with top production, noting that many high-quality articles had been published about this filed. Although Evidence-based Complimentary and Alternative Medicine (IF2.650) had 33 publications, its IF values were less than 5. Maintaining the quality of the work as well as increasing the output will help enhancing the academic impact of journal. Among the most commonly cited journals, Nature (IF69.504), Science (IF63.714) and Nucleic Acids Research (IF19.160) had IF values higher than 15, indicating that the quality of the evidences from the above periodicals was high, and had strong persuasiveness and influence.</p>
<p>The analysis of co-cited articles and literature cluster reflect the core content and hot topics in a field, and the highly cited documents can prompt the core research and high-intensity burst can represent emerging academic hotspots. (<xref ref-type="bibr" rid="B8">Chen et al., 2022</xref>). Top three articles with highest citations are as follow: &#x2170;) Ru JL in 2014 (94 citations), which also has strongest burst intensity. This research established a traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP) based on Chinese herbal Systems pharmacology, integrating the chemical properties, targets, related diseases and interaction networks of Chinese herbal medicines (<xref ref-type="bibr" rid="B44">Ru et al., 2014</xref>). It is manifested that the research and development of Chinese herbal medicine employing systems pharmacology may be a new hotspot in current period. &#x2171;) Shannon P in 2003 (73 citations) developed a generic model for biomolecular interaction networks and states: Cytoscape (<xref ref-type="bibr" rid="B45">Shannon et al., 2003</xref>). &#x2172;) Hopkins AL in 2008 (68 citations) reported that based on drug, disease, gene and target interaction network, network pharmacology can systematically and comprehensively understand the drugs on the body&#x2019;s disease network intervention and impact, guiding the discovery of new drugs and new targets (<xref ref-type="bibr" rid="B29">Hopkins, 2008</xref>). Briefly, the highly cited articles are all new explorations based on databases and interactive networks, indicating that network pharmacology is being widely applied to the research of molecules and diseases and the development of drugs.</p>
<p>Additionally, &#x201c;network pharmacology&#x201d; (Cluster ID 0&#x23;) with 68 references was the largest cluster, which covered network pharmacology in the applications of drug discovery, protein, gene etc. Peng Zeng et al. revealed the key components in Ginkgo Folium and its mechanism in the treatment of AD employing network pharmacology (<xref ref-type="bibr" rid="B56">Zeng et al., 2021</xref>). Szklarczyk et al. established a database of high-throughput text mining and internet clustering by collecting information of protein-protein interaction (<xref ref-type="bibr" rid="B48">Szklarczyk et al., 2019</xref>). Pinerol J et al. developed DisGeNET, integrating human disease-related genes, scientific literature data, animal model studies, and the GWAS catalog, which play an significant role in the research of molecular basis in disease and its side effects, characteristics of disease genes, drug therapeutic effects and adverse reactions, validation of gene prediction of disease and evaluation of text mining methods (<xref ref-type="bibr" rid="B41">Pinero et al., 2017</xref>). Moreover, the latest cluster includes &#x201c;alzheimers disease&#x201d; (Cluster ID 1&#x23;), &#x201c;network pharmacology&#x201d; (Cluster ID 0&#x23;), &#x201c;network medicine&#x201d; (Cluster ID 2&#x23;) and &#x201c;epimedii herba&#x201d; (Cluster ID 9&#x23;). It was found that multiple clustering topics were related to network pharmacology, which also had high frequency in the keyword co-occurrence network, indicating that network pharmacology is the research core in this field. Finally, the article with the highest centrality is Geert H in 2020, which explored new approaches for molecular, target recognition, therapeutic drug discovery and development in central nervous system based on quantitative systems pharmacology (QSP) (<xref ref-type="bibr" rid="B25">Geerts et al., 2020</xref>). In conclusion, based on the analysis of literature clustering and co-citation, network pharmacology has recently emerged as the flash point of this filed, and has received extensive concern from scholars around the world.</p>
<p>Based on the joint analysis of keywords&#x2019; frequency and emergence, the study on therapy for AD especially TCM draw extensive attention recently. These TCM therapy of AD included the follow aspects: 1) reducing the deposition of A&#x3b2; peptide and removing the hyperphosphorylation TAU protein: gypenosides XVII enhanced the autophagy dependent removal of A&#x3b2; through TFEB activation (<xref ref-type="bibr" rid="B36">Meng et al., 2016</xref>). Geniposide decreased amyloid deposition and promoted autophagy by modulating mTOR signal pathway (<xref ref-type="bibr" rid="B58">Zhang et al., 2019</xref>). Resveratrol by means of modulating GSK-3&#x3b2;, CaMKII, and PP2A to reduce TAU deposition (<xref ref-type="bibr" rid="B27">He et al., 2016</xref>). 2) regulating cholinergic neurotransmitters: huperzine A was proven to be a powerful neuroprotective agent in inhibiting robust anti-acetylcholinesterase (ACHE) activity (<xref ref-type="bibr" rid="B20">Friedli and Inestrosa, 2021</xref>). 3) improving blood vessel and microcirculation: combination therapy of Buyang Huanwu Tang and MSCs transplantation may repair vascular injury by up-regulating the expression of VEGF and Ki-67 (<xref ref-type="bibr" rid="B57">Zhang et al., 2010</xref>). 4) reducing oxidative stress and inflammation: Danggui-Shaoyao-San can improve the apoptosis of brain neurons induced by oxidative stress (<xref ref-type="bibr" rid="B34">Lan et al., 2012</xref>), Ginkgolide B (GB) inhibits NLRP3 inflammasome activation and promotes microglia M2 polarization to reduce neuroinflammation (<xref ref-type="bibr" rid="B56">Zeng et al., 2021</xref>). Crocin can attenuate malathion-induced changes and cognitive impairment in the nervous system by reducing oxidative stress and inflammation (<xref ref-type="bibr" rid="B37">Mohammadzadeh et al., 2020</xref>). 5) anti-apoptotic effect of neurons: Ginsenoside RG2 can protect PC12 cells from A&#x3b2;25-35-induced apoptosis by enhancing PI3K/Akt signaling pathway (<xref ref-type="bibr" rid="B11">Cui et al., 2017</xref>). Above all, plenty of evidences have proved that the natural extract of TCM has great potential in the treatment of AD by multiple pathways and targets (<xref ref-type="bibr" rid="B32">Jarrell et al., 2018</xref>). Network pharmacology is a new approach to the study of drugs, diseases, and targets in TCM, which mainly contains: 1) exploring the mechanisms of Chinese herbal formulae: Qu et al. analyzed the antidepressant activity of Huang-Lian Jie-Du Decoction (HLJDD) employing network pharmacology and metabolomics, and found that SLC6A4 and MAOA in tryptophan metabolism may be the major antidepressant targets of HLJDD (<xref ref-type="bibr" rid="B42">Qu et al., 2021</xref>). 2) identifying the active ingredients of Chinese herbal compound: Wu et al. analyzed the composition and targets of Citri Reticulatae Pericarpium based on systems pharmacology methods and vitro experiments, and validated potential molecular mechanisms in the treatment of liver injury (<xref ref-type="bibr" rid="B53">Wu et al., 2021</xref>). Taken together, network pharmacology in TCM therapy especially for AD may become a new focus and direction of academic research in the future.</p>
<sec id="s4-1">
<title>Limitation</title>
<p>This study visualized the relationships between network pharmacology and NDs to understand their trends and hotspots through the use of bibliometrics. However, there are a few shortcomings to this study. For instance, due to the limitations of current scientific measurement software, it is difficult to analyze data from multiple databases simultaneously, so this study only utilized the WOSCC database. Moreover, this study only included articles and reviews, not abstracts, conferences, or books. Therefore, more comprehensive studies and databases could be undertaken in the future for more complete and accurate analysis.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>In conclusion, researches on NDs employing network pharmacology have been extensively conducted, and the number of articles retrieved has shown a clear increasing trend, especially in 2014&#x2013;2022. China was the most prolific country, while Chinese Academy of Sciences also made important research achievements, which was important force in the development of this field. Moreover, Geerts H was the leader in this field by publishing the most articles. The main research focuses in this area are the development and application of network pharmacology and the treatment of AD. Medication of NDs, especially TCM, will become the focus of future research. In addition, the application of network pharmacology in Chinese herbal compound have great research prospects. Collectively, our study conducted a systematic visualization of literatures on network pharmacology in NDs, showed the main aspects of the subject and provides the direction and reference for further researches into diseases and drugs.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s7">
<title>Author contributions</title>
<p>JZ and ZW designed the methodology and research plan. SH and CW selected and verified the literature. QL and GL conducted software analysis. JZ and QL drafted and retouched the manuscript. XL and DW revised and approved the final version of manuscript</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This work was supported by Hainan Provincial Natural Science Foundation of China (grant no. 2019RC365) and Guangzhou Key Laboratory of Neuropathic Pain Mechanism at Spinal Cord Level (202102100005).</p>
</sec>
<ack>
<p>We really appreciate for the guest editors&#x2019; inspiration and continuous support on this research.</p>
</ack>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Understanding the &#x27;g-index&#x27; and the &#x27;e-index</article-title>. <source>Semin. Ophthalmol.</source> <volume>36</volume> (<issue>4</issue>), <fpage>139</fpage>. <pub-id pub-id-type="doi">10.1080/08820538.2021.1922975</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barabasi</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Gulbahce</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Loscalzo</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Network medicine: A network-based approach to human disease</article-title>. <source>Nat. Rev. Genet.</source> <volume>12</volume> (<issue>1</issue>), <fpage>56</fpage>&#x2013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1038/nrg2918</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertoli-Barsotti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lando</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>A theoretical model of the relationship between the h-index and other simple citation indicators</article-title>. <source>Scientometrics</source> <volume>111</volume> (<issue>3</issue>), <fpage>1415</fpage>&#x2013;<lpage>1448</lpage>. <pub-id pub-id-type="doi">10.1007/s11192-017-2351-9</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Breijyeh</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Karaman</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Comprehensive review on Alzheimer&#x27;s disease: Causes and treatment</article-title>. <source>Molecules</source> <volume>25</volume> (<issue>24</issue>), <fpage>5789</fpage>. <pub-id pub-id-type="doi">10.3390/molecules25245789</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>Y. P.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y. M.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature</article-title>. <source>J. Am. Soc. Inf. Sci. Tec.</source> <volume>57</volume>, <fpage>359</fpage>&#x2013;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.44.2.359-365.2006</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Searching for intellectual turning points: Progressive knowledge domain visualization</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>101</volume> (<issue>01</issue>), <fpage>5303</fpage>&#x2013;<lpage>5310</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0307513100</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Visualizing a field of research: A methodology of systematic scientometric reviews</article-title>. <source>PLoS One</source> <volume>14</volume> (<issue>10</issue>), <fpage>e0223994</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0223994</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Q.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Global trends in research of lipid metabolism in T lymphocytes from 1985 to 2022: A bibliometric analysis</article-title>. <source>Front. Immunol.</source> <volume>13</volume>, <fpage>884030</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2022.884030</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Publication trends and hot spots in postoperative cognitive dysfunction research: A 20-year bibliometric analysis</article-title>. <source>J. Clin. Anesth.</source> <volume>67</volume>, <fpage>110012</fpage>. <pub-id pub-id-type="doi">10.1016/j.jclinane.2020.110012</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Z. H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Emerging trends in regenerative medicine: A scientometric analysis in CiteSpace</article-title>. <source>Expert Opin. Biol. Ther.</source> <volume>12</volume> (<issue>15</issue>), <fpage>593</fpage>&#x2013;<lpage>608</lpage>. <pub-id pub-id-type="doi">10.1517/14712598.2012.674507</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Ginsenoside Rg2 protects PC12 cells against beta-amyloid(25-35)-induced apoptosis via the phosphoinositide 3-kinase/Akt pathway</article-title>. <source>Chem. Biol. Interact.</source> <volume>275</volume>, <fpage>152</fpage>&#x2013;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2017.07.021</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Bibliometric and visual analysis of vascular calcification research</article-title>. <source>Front. Pharmacol.</source> <volume>12</volume>, <fpage>690392</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.690392</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dugger</surname>
<given-names>B. N.</given-names>
</name>
<name>
<surname>Dickson</surname>
<given-names>D. W.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Pathology of neurodegenerative diseases</article-title>. <source>Cold Spring Harb. Perspect. Biol.</source> <volume>9</volume> (<issue>7</issue>), <fpage>a028035</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a028035</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2017a</year>). <article-title>Quantitative and systems pharmacology 3. Network-based identification of new targets for natural products enables potential uses in aging-associated disorders</article-title>. <source>Front. Pharmacol.</source> <volume>8</volume>, <fpage>747</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2017.00747</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Discovery of multitarget-directed ligands against Alzheimer&#x27;s disease through systematic prediction of chemical-protein interactions</article-title>. <source>J. Chem. Inf. Model.</source> <volume>55</volume> (<issue>1</issue>), <fpage>149</fpage>&#x2013;<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1021/ci500574n</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pieper</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Nussinov</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bekris</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Leverenz</surname>
<given-names>J. B.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Harnessing endophenotypes and network medicine for Alzheimer&#x27;s drug repurposing</article-title>. <source>Med. Res. Rev.</source> <volume>40</volume> (<issue>6</issue>), <fpage>2386</fpage>&#x2013;<lpage>2426</lpage>. <pub-id pub-id-type="doi">10.1002/med.21709</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2017b</year>). <article-title>Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment</article-title>. <source>J. Ethnopharmacol.</source> <volume>196</volume>, <fpage>281</fpage>&#x2013;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2016.11.034</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Endophenotype-based <italic>in silico</italic> network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer&#x27;s disease</article-title>. <source>Nat. Aging</source> <volume>1</volume> (<issue>12</issue>), <fpage>1175</fpage>&#x2013;<lpage>1188</lpage>. <pub-id pub-id-type="doi">10.1038/s43587-021-00138-z</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freeman</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>1978</year>). <article-title>Centrality in social networks conceptual clarification</article-title>. <source>Soc. Netw.</source> <volume>1</volume>, <fpage>215</fpage>&#x2013;<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1016/0378-8733(78)90021-7</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Friedli</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Inestrosa</surname>
<given-names>N. C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Huperzine A and its neuroprotective molecular signaling in Alzheimer&#x27;s disease</article-title>. <source>Molecules</source> <volume>26</volume> (<issue>21</issue>), <fpage>6531</fpage>. <pub-id pub-id-type="doi">10.3390/molecules26216531</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<collab>GBD 2016 Dementia Collaborators</collab> (<year>2019</year>). <article-title>Global, regional, and national burden of Alzheimer&#x27;s disease and other dementias, 1990-2016: A systematic analysis for the global burden of disease study 2016</article-title>. <source>Lancet Neurol.</source> <volume>18</volume> (<issue>1</issue>), <fpage>88</fpage>&#x2013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(18)30403-4</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gal</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Glanzel</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sipido</surname>
<given-names>K. R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Mapping cross-border collaboration and communication in cardiovascular research from 1992 to 2012</article-title>. <source>Eur. Heart J.</source> <volume>38</volume> (<issue>16</issue>), <fpage>1249</fpage>&#x2013;<lpage>1258</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehw459</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garfield</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Paris</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Stock</surname>
<given-names>W. G.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>HistCite&#x2122;: A software tool for informetric analysis of citation linkage</article-title>. <source>NFD Information-Wissenschaft Prax.</source> <volume>2057</volume>, <fpage>2391</fpage>&#x2013;<lpage>2400</lpage>.</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geerts</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dacks</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Devanarayan</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Khachaturian</surname>
<given-names>Z. S.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>M. F.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Brain Health Modeling, IBig data to smart data in Alzheimer&#x27;s disease: The brain health modeling initiative to foster actionable knowledge</article-title>. <source>Alzheimers Dement.</source> <volume>12</volume> (<issue>9</issue>), <fpage>1014</fpage>&#x2013;<lpage>1021</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2016.04.008</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geerts</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wikswo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>van der Graaf</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>J. P. F.</given-names>
</name>
<name>
<surname>Gaiteri</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Quantitative systems pharmacology for neuroscience drug discovery and development: Current status, opportunities, and challenges</article-title>. <source>CPT Pharmacometrics Syst. Pharmacol.</source> <volume>9</volume> (<issue>1</issue>), <fpage>5</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1002/psp4.12478</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Network pharmacology-based approach to understand the effect and mechanism of Danshen against anemia</article-title>. <source>J. Ethnopharmacol.</source> <volume>282</volume>, <fpage>114615</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2021.114615</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Rizak</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Resveratrol attenuates formaldehyde induced hyperphosphorylation of tau protein and cytotoxicity in N2a cells</article-title>. <source>Front. Neurosci.</source> <volume>10</volume>, <fpage>598</fpage>. <pub-id pub-id-type="doi">10.3389/fnins.2016.00598</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirsch</surname>
<given-names>J. E.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>An index to quantify an individual&#x27;s scientific research output</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>102</volume> (<issue>46</issue>), <fpage>16569</fpage>&#x2013;<lpage>16572</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0507655102</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hopkins</surname>
<given-names>A. L.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Network pharmacology: The next paradigm in drug discovery</article-title>. <source>Nat. Chem. Biol.</source> <volume>4</volume> (<issue>11</issue>), <fpage>682</fpage>&#x2013;<lpage>690</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.118</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Babbar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hasselbalch</surname>
<given-names>S. G.</given-names>
</name>
<name>
<surname>Croteau</surname>
<given-names>D. L.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Ageing as a risk factor for neurodegenerative disease</article-title>. <source>Nat. Rev. Neurol.</source> <volume>15</volume> (<issue>10</issue>), <fpage>565</fpage>&#x2013;<lpage>581</lpage>. <pub-id pub-id-type="doi">10.1038/s41582-019-0244-7</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of beta-amyloid in APP/tau/PS1 mouse model of Alzheimer&#x27;s disease</article-title>. <source>Exp. Gerontol.</source> <volume>91</volume>, <fpage>25</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2017.02.004</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jarrell</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Network medicine for Alzheimer&#x27;s disease and traditional Chinese medicine</article-title>. <source>Molecules</source> <volume>23</volume> (<issue>5</issue>), <fpage>1143</fpage>. <pub-id pub-id-type="doi">10.3390/molecules23051143</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Editorial: Network pharmacology and traditional medicine</article-title>. <source>Front. Pharmacol.</source> <volume>11</volume>, <fpage>1194</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2020.01194</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Danggui-Shaoyao-San ameliorates cognition deficits and attenuates oxidative stress-related neuronal apoptosis in d-galactose-induced senescent mice</article-title>. <source>J. Ethnopharmacol.</source> <volume>141</volume> (<issue>1</issue>), <fpage>386</fpage>&#x2013;<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2012.02.050</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>C. W.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Polysaccharides from medicinal herbs as potential therapeutics for aging and age-related neurodegeneration</article-title>. <source>Rejuvenation Res.</source> <volume>17</volume> (<issue>2</issue>), <fpage>201</fpage>&#x2013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1089/rej.2013.1513</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Gypenoside XVII enhances lysosome biogenesis and autophagy flux and accelerates autophagic clearance of amyloid-beta through TFEB activation</article-title>. <source>J. Alzheimers Dis.</source> <volume>52</volume> (<issue>3</issue>), <fpage>1135</fpage>&#x2013;<lpage>1150</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-160096</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammadzadeh</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Abnous</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Razavi</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Hosseinzadeh</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Crocin-protected malathion-induced spatial memory deficits by inhibiting TAU protein hyperphosphorylation and antiapoptotic effects</article-title>. <source>Nutr. Neurosci.</source> <volume>23</volume> (<issue>3</issue>), <fpage>221</fpage>&#x2013;<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1080/1028415X.2018.1492772</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mt</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Neurodegenerative diseases</article-title>. <source>Nature</source> <volume>539</volume> (<issue>7628</issue>), <fpage>179</fpage>. <pub-id pub-id-type="doi">10.1038/539179a</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ninkov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Maggio</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Bibliometrics: Methods for studying academic publishing</article-title>. <source>Perspect. Med. Educ.</source> <volume>11</volume> (<issue>3</issue>), <fpage>173</fpage>&#x2013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1007/s40037-021-00695-4</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nogales</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mamdouh</surname>
<given-names>Z. M.</given-names>
</name>
<name>
<surname>List</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kiel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Casas</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Network pharmacology: Curing causal mechanisms instead of treating symptoms</article-title>. <source>Trends Pharmacol. Sci.</source> <volume>43</volume> (<issue>2</issue>), <fpage>136</fpage>&#x2013;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2021.11.004</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinero</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bravo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Queralt-Rosinach</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gutierrez-Sacristan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Deu-Pons</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Centeno</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants</article-title>. <source>Nucleic Acids Res.</source> <volume>45</volume> (<issue>D1</issue>), <fpage>D833</fpage>&#x2013;<lpage>D839</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw943</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Heng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>P. Y.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>S. J.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Analysis of antidepressant activity of huang-lian jie-du decoction through network pharmacology and metabolomics</article-title>. <source>Front. Pharmacol.</source> <volume>12</volume>, <fpage>619288</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.619288</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Spiros</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Geerts</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Simulations of symptomatic treatments for Alzheimer&#x27;s disease: Computational analysis of pathology and mechanisms of drug action</article-title>. <source>Alzheimers Res. Ther.</source> <volume>4</volume> (<issue>6</issue>), <fpage>50</fpage>. <pub-id pub-id-type="doi">10.1186/alzrt153</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ru</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Tcmsp: A database of systems pharmacology for drug discovery from herbal medicines</article-title>. <source>J. Cheminform</source> <volume>6</volume>, <fpage>13</fpage>. <pub-id pub-id-type="doi">10.1186/1758-2946-6-13</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shannon</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Markiel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ozier</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Baliga</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Ramage</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Cytoscape: A software environment for integrated models of biomolecular interaction networks</article-title>. <source>Genome Res.</source> <volume>13</volume> (<issue>11</issue>), <fpage>2498</fpage>&#x2013;<lpage>2504</lpage>. <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solanki</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Parihar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Parihar</surname>
<given-names>M. S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Neurodegenerative diseases: From available treatments to prospective herbal therapy</article-title>. <source>Neurochem. Int.</source> <volume>95</volume>, <fpage>100</fpage>&#x2013;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2015.11.001</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soteriades</surname>
<given-names>F. M.</given-names>
</name>
<name>
<surname>Falagas</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Comparison of amount of biomedical research originating from the European Union and the United States</article-title>. <source>BMJ</source> <volume>331</volume> (<issue>7510</issue>), <fpage>192</fpage>&#x2013;<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.331.7510.192</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szklarczyk</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gable</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Lyon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Junge</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wyder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huerta-Cepas</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</article-title>. <source>Nucleic Acids Res.</source> <volume>47</volume> (<issue>D1</issue>), <fpage>D607</fpage>&#x2013;<lpage>D613</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1131</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<collab>The Lancet</collab> (<year>2016</year>). <article-title>Alzheimer&#x27;s disease: Expedition into the unknown</article-title>. <source>Lancet</source> <volume>388</volume> (<issue>10061</issue>), <fpage>2713</fpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(16)32457-6</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Eck</surname>
<given-names>N. J.</given-names>
</name>
<name>
<surname>Waltman</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Software survey: VOSviewer, a computer program for bibliometric mapping</article-title>. <source>Scientometrics</source> <volume>84</volume> (<issue>2</issue>), <fpage>523</fpage>&#x2013;<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1007/s11192-009-0146-3</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>What has traditional Chinese medicine delivered for modern medicine?</article-title> <source>Expert Rev. Mol. Med.</source> <volume>20</volume>, <fpage>e4</fpage>. <pub-id pub-id-type="doi">10.1017/erm.2018.3</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z. Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>TCM network pharmacology: A new trend towards combining computational, experimental and clinical approaches</article-title>. <source>Chin. J. Nat. Med.</source> <volume>19</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/s1875-5364(21)60001-8</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Systems pharmacology study of the anti-liver injury mechanism of Citri Reticulatae Pericarpium</article-title>. <source>Front. Pharmacol.</source> <volume>12</volume>, <fpage>618846</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2021.618846</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The future landscape of macrophage research in cardiovascular disease: A bibliometric analysis</article-title>. <source>Curr. Probl. Cardiol.</source> <volume>47</volume> (<issue>10</issue>), <fpage>101311</fpage>. <pub-id pub-id-type="doi">10.1016/j.cpcardiol.2022.101311</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yadava</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Patrick</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Ananth</surname>
<given-names>C. V.</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Brandt</surname>
<given-names>J. S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Top-cited articles in the journal: A bibliometric analysis</article-title>. <source>Am. J. Obstet. Gynecol.</source> <volume>220</volume> (<issue>1</issue>), <fpage>12</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajog.2018.11.1091</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>A network pharmacology approach to uncover the key ingredients in Ginkgo Folium and their anti-Alzheimer&#x2019;s disease mechanisms</article-title>. <source>Aging (Albany NY)</source> <volume>13</volume> (<issue>14</issue>), <fpage>18993</fpage>&#x2013;<lpage>19012</lpage>. <pub-id pub-id-type="doi">10.18632/aging.203348</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y. K.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X. Y.</given-names>
</name>
<name>
<surname>Che</surname>
<given-names>Z. Y.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Effects of Buyang Huanwu Tang combined with bone marrow mesenchymal stem cell transplantation on the expression of VEGF and ki-67 in the brain tissue of the cerebral ischemia-reperfusion model rat</article-title>. <source>J. Traditional Chin. Med.</source> <volume>30</volume> (<issue>4</issue>), <fpage>278</fpage>&#x2013;<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1016/s0254-6272(10)60056-8</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Geniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of Alzheimer&#x27;s disease</article-title>. <source>Aging (Albany NY)</source> <volume>1111</volume> (<issue>212</issue>), <fpage>536</fpage>&#x2013;<lpage>548</lpage>. <pub-id pub-id-type="doi">10.18632/aging.101759</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bekris</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Pieper</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Leverenz</surname>
<given-names>J. B.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>AlzGPS: A genome-wide positioning systems platform to catalyze multi-omics for Alzheimer&#x27;s drug discovery</article-title>. <source>Alzheimers Res. Ther.</source> <volume>13</volume> (<issue>1</issue>), <fpage>24</fpage>. <pub-id pub-id-type="doi">10.1186/s13195-020-00760-w</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>